Bad News For Pharmaceutical Companies and For Consumers

First, there was Fen-Phen with its promises of weight loss, but which carried the additional benefits of valvular heart disease and pulmonary hypertension. Then there was Vioxx, an NSAID which delivered great benefits in treating arthritis, but only if you weren’t too concerned about the minor risks of heart attack and stroke. And that’s just two of the major recalls. There is also quite a list of lesser-known drugs that were voluntarily (cough!) withdrawn from the market. There are also some like Crestor that have had certain high doses pulled from the market, lesser doses still being sold.
Here are two more from the past few months:
Diabetes Drugs May Be Related To Fracture Risk
After adjusting for other risk factors, individuals who were currently taking rosiglitazone and pioglitazone had approximately double or triple the odds of hip and other non-spine fractures than those who did not take these drugs. The odds for fracture were increased among patients who took the drugs for approximately 12 to 18 months and the risk was highest for those with two or more years of therapy.
Osteoporosis Drug Fosamax Linked To Heart Problem, Study Suggests
“Having ever used alendronate was associated with an 86 percent higher risk of newly detected atrial fibrillation compared with never having used the drug,” said Dr. Heckbert, who is also an affiliate investigator at the Group Health Center for Health Studies.
It’s a good thing Sally Field is taking once-a-month Boniva. I suppose you could take Fosamax with your diabetes drugs to try to protect your bones, at the expense of your heart. Or you could face the reality that diabetes especially is a lifestyle disease that can be treated with diet without sacrificing your bones.
It’s interesting how all of these drugs make it through the supposedly rigorous FDA approval process. In the book Death By Prescription, Dr. Ray Strand discusses the entire process, conflicts of interest and all. But there’s another odious force working behind the scenes to keep complete information from you. And yes, I am bold enough to say that it’s not innocent. I wrote once before about ghost writing of studies by pharmaceutical companies. Here is an article with a nice step-by-step of how the ghost-writing process happens.
Let’s not forget about recent trials showing the “wonder combination” of Zetia and Zocor, marketed as Vytorin. This combination of a statin drug (Zocor) and a non-statin drug (Zetia) was supposed to work even better than either drug by itself. Too bad for the millions of people that took the drug that it actually caused arterial plaques to grow at nearly twice the rate of patients taking Zocor alone. Bad news, right? Not as bad as the news that Schering-Plough and Merck withheld the results of the study for two years. Nefarious? The companies say no, but if the data had been positive, it’s unlikely it would have taken quite so long.
If you’re interested in keeping up on what’s happening in the world of drug recalls, check the Drug Recalls site. I won’t say don’t take pharmaceuticals. There are definite situations that call for the use of drugs. But don’t take drugs without exhausting other options and without considering the serious side effects that some of them carry. Don’t take drugs without asking lots of questions. And don’t forget that you’re in charge of your health; a doctor is simply there to help guide you along the path.
How do we get people to take control of their health rather than putting it in the hands of companies with a motive to get them on pharmaceuticals?
If you enjoyed this post, share it on StumbleUpon or Health Ranker (or both!)
- Other Stuff You'll Enjoy:
- What I’m Reading: Death By Prescription
- Digest - Statins, Probiotics, Cataracts, and More
- Ghost Authorship of Studies
- NEJM Gives in to Pharma Conflicts of Interest
- More Crap from the FDA
Print This Post
Filed in Medicine & Pharmaceuticals 3 Comments so far
Subscribe



Neal W. on 09 Jul 2008 at 9:09 am #
We don’t need an FDA. As with all government programs it has no incentive to provide a good service, and the worse it does the more money and personnel it receives.
The free market could handle drug testing. Because people are more likely to buy a product that has been tested, drug and food companies would pay money to feature a logo from food/drug testing companies showing that the product is safe. The testing companies have an incentive to be honest because if they are found to be doing poor testing the consumer will lose confidence in their logo. Food companies who use a different testing company that has not been outed with doing bad testing will then increase their market share as consumers shift their preferences. The company with bad food/drugs will then have to switch their testing services to the other testing company and the bad testing company will go out of business.
DaveC - DaveGetsFit on 09 Jul 2008 at 1:39 pm #
When you say diabetes is a “lifestyle disease”, isn’t that only true for Type II? I also think it’s a sad commentary that the other name for Type II was “adult onset.” That name no longer appears to be valid.
» Arlington, Virginia, Washington, DC Official Crossfit Affiliate - Group Personal Training on 11 Jul 2008 at 7:37 am #
[...] Bad News for Pharmaceutical Companies and Consumers [...]